biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by frohlir944on Sep 20, 2017 12:16pm

232 Views

Post# 26720034

disingenuous to support your trade

Digi, what you are doing is extremely disingenuous to support your trades, constantly buying and selling small lots. What you are not saying is that a company with a single drug just gained 3 Billion in market share in one day (that would put our stock price at $50 to $60 per share) And we can do it with an endless number of drugs because we have a Tow Truck (Xb3/transcend) and not just a single drug.

Your takeaway should have been what happens when we get to do that over and over again and our stock jumps by the same level each time!

Bullboard Posts

The top 10 Canadian medical stocks